MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

Search

Nektar Therapeutics

Fermé

73.61 -4.2

Résumé

Variation du prix de l'action

24h

Actuel

Min

73.51

Max

76.84

Chiffres clés

By Trading Economics

Revenu

-557K

-36M

Ventes

10M

22M

BPA

-1.29

Marge bénéficiaire

-165.447

Employés

63

EBITDA

10M

-19M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+54.38% upside

Dividendes

By Dow Jones

Prochains Résultats

7 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-63M

1.9B

Ouverture précédente

77.81

Clôture précédente

73.61

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

Nektar Therapeutics Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

6 avr. 2026, 23:17 UTC

Résultats

Samsung Forecasts Record First-Quarter Operating Profit

6 avr. 2026, 23:00 UTC

Actions en Tendance

Stocks to Watch: Health Insurers, Mawson, Owlet

6 avr. 2026, 22:13 UTC

Principaux Mouvements du Marché

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6 avr. 2026, 21:46 UTC

Acquisitions, Fusions, Rachats

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6 avr. 2026, 17:09 UTC

Principaux Mouvements du Marché

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6 avr. 2026, 16:56 UTC

Principaux Événements d'Actualité

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6 avr. 2026, 14:47 UTC

Principaux Mouvements du Marché

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7 avr. 2026, 00:00 UTC

Principaux Événements d'Actualité

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6 avr. 2026, 23:58 UTC

Market Talk
Principaux Événements d'Actualité

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6 avr. 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6 avr. 2026, 23:36 UTC

Market Talk

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6 avr. 2026, 23:15 UTC

Market Talk

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6 avr. 2026, 22:52 UTC

Market Talk

Global Equities Roundup: Market Talk

6 avr. 2026, 22:52 UTC

Market Talk

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6 avr. 2026, 22:14 UTC

Market Talk

Correction to Live Cattle Futures Article

6 avr. 2026, 20:56 UTC

Market Talk

Mexican Private Consumption Fell in January -- Market Talk

6 avr. 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

6 avr. 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6 avr. 2026, 19:58 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6 avr. 2026, 19:58 UTC

Market Talk

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6 avr. 2026, 19:11 UTC

Market Talk

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6 avr. 2026, 19:06 UTC

Market Talk

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6 avr. 2026, 19:03 UTC

Market Talk

Global Energy Roundup: Market Talk

6 avr. 2026, 19:03 UTC

Market Talk

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6 avr. 2026, 18:36 UTC

Acquisitions, Fusions, Rachats

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 avr. 2026, 17:59 UTC

Market Talk
Principaux Événements d'Actualité

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6 avr. 2026, 17:13 UTC

Acquisitions, Fusions, Rachats

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 avr. 2026, 16:33 UTC

Market Talk

Oil Futures Steady as Market Awaits Trump -- Market Talk

6 avr. 2026, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

6 avr. 2026, 14:59 UTC

Résultats

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Comparaison

Variation de prix

Nektar Therapeutics prévision

Objectif de Prix

By TipRanks

54.38% hausse

Prévisions sur 12 Mois

Moyen 118.86 USD  54.38%

Haut 165 USD

Bas 68 USD

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

8 ratings

7

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

0.5949 / 0.7406Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Bearish Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

help-icon Live chat